Evidence map›Paper›PMID 20451243›Full record

ArticleCell2010

Peroxisomes are signaling platforms for antiviral innate immunity.

Evelyn Dixit, Steeve Boulant, Yijing Zhang, Amy S Y Lee, Charlotte Odendall, Bennett Shum, Nir Hacohen, Zhijian J Chen, Sean P Whelan, Marc Fransen and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 497 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
497citing papers in PubMed, 1 pooled it
22.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

497 citing papers in PubMed, 1 synthesis or guideline pooled it, 810 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Macrophage peroxisomes at the crossroads of inflammation.Immunometabolism (Cobham, Surrey) · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Telomere Crisis Shapes Cancer Evolution.Cold Spring Harbor perspectives in biology · 2026
    Review
  18. Role of autophagy in antiviral innate immunity.Cellular & molecular biology letters · 2026
    Review
  19. Article
  20. Article

437 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Evelyn DixitDivision of Gastroenterology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.
Steeve Boulant
Yijing Zhang
Amy S Y Lee
Charlotte Odendall
Bennett Shum
Nir Hacohen
Zhijian J Chen
Sean P Whelan
Marc Fransen
Max L Nibert
Giulio Superti-Furga
Jonathan C Kagan
Harvard University · USAustrian Academy of Sciences · ATBroad Institute · USBoston Children's Hospital · USHoward Hughes Medical Institute · USKU Leuven · BE

Funding

RNA Processing in Non-Segmented Minus-Strand RNA VirusesR37AI059371 · NIAID · WASHINGTON UNIVERSITY · PI WHELAN, SEAN PJ · 2015 to 2024
$5.4M
RNA Processing in Non-Segmented Minus-Strand RNA VirusesR01AI059371 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WHELAN, SEAN PJ · 2005 to 2015
$3.9M
Howard Hughes Medical InstituteNIAID NIH HHS AI059371NIAID NIH HHS R01 AI059371
6 · The paper itself

Abstract

Peroxisomes have long been established to play a central role in regulating various metabolic activities in mammalian cells. These organelles act in concert with mitochondria to control the metabolism of lipids and reactive oxygen species. However, while mitochondria have emerged as an important site of antiviral signal transduction, a role for peroxisomes in immune defense is unknown. Here, we report that the RIG-I-like receptor (RLR) adaptor protein MAVS is located on peroxisomes and mitochondria. We find that peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state. Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response. The interferon regulatory factor IRF1 plays a crucial role in regulating MAVS-dependent signaling from peroxisomes. These results establish that peroxisomes are an important site of antiviral signal transduction.

Indexed as

Immunity, InnateSignal TransductionAdaptor Proteins, Signal TransducingAnimalsCell LineChlorocebus aethiopsFibroblastsHepatocytesHumansInterferonsMiceMitochondriaPeroxisomesVero CellsAdaptor Proteins, Signal TransducingInterferonsMAVS protein, humanMAVS protein, mouse

Identifiers

PMID20451243
PMCPMC3670185
OpenAlexW2087804239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.